Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists), Monoamine reuptake inhibitor |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (23 Aug 1965) |
Regulation- |
Molecular FormulaC20H24ClN |
InChIKeyKFYRPLNVJVHZGT-UHFFFAOYSA-N |
CAS Registry549-18-8 |